Semiconductors
Compare Stocks
5 / 10Stock Comparison
RMBS vs SSNC vs IPGP vs CEVA vs SLAB
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Semiconductors
Semiconductors
Semiconductors
RMBS vs SSNC vs IPGP vs CEVA vs SLAB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Software - Application | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $13.69B | $16.92B | $4.31B | $810M | $7.17B |
| Revenue (TTM) | $721M | $6.41B | $1.04B | $108M | $785M |
| Net Income (TTM) | $230M | $810M | $29M | $-11M | $-65M |
| Gross Margin | 77.0% | 48.0% | 37.6% | 87.2% | 58.2% |
| Operating Margin | 35.9% | 23.1% | 0.3% | -10.1% | -9.0% |
| Forward P/E | 42.9x | 10.1x | 62.6x | 67.3x | 80.4x |
| Total Debt | $44M | $7.65B | $0.00 | $6M | $0.00 |
| Cash & Equiv. | $183M | $3.57B | $404M | $18M | $364M |
RMBS vs SSNC vs IPGP vs CEVA vs SLAB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Rambus Inc. (RMBS) | 100 | 814.7 | +714.7% |
| SS&C Technologies H… (SSNC) | 100 | 121.0 | +21.0% |
| IPG Photonics Corpo… (IPGP) | 100 | 65.4 | -34.6% |
| CEVA, Inc. (CEVA) | 100 | 97.8 | -2.2% |
| Silicon Laboratorie… (SLAB) | 100 | 232.4 | +132.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RMBS vs SSNC vs IPGP vs CEVA vs SLAB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RMBS carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 10.1% 10Y total return vs SLAB's 375.0%
- 31.9% margin vs CEVA's -10.5%
- +148.9% vs SSNC's -7.3%
- 15.5% ROA vs SLAB's -5.1%, ROIC 17.1% vs -6.9%
SSNC is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 12 yrs, beta 0.79, yield 1.4%
- Beta 0.79, yield 1.4%, current ratio 1.07x
- Lower P/E (10.1x vs 80.4x)
- Beta 0.79 vs RMBS's 3.00
IPGP lags the leaders in this set but could rank higher in a more targeted comparison.
CEVA is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 2.76, Low D/E 2.1%, current ratio 7.09x
SLAB ranks third and is worth considering specifically for growth exposure.
- Rev growth 34.3%, EPS growth 66.6%, 3Y rev CAGR -8.5%
- 34.3% revenue growth vs IPGP's 2.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 34.3% revenue growth vs IPGP's 2.7% | |
| Value | Lower P/E (10.1x vs 80.4x) | |
| Quality / Margins | 31.9% margin vs CEVA's -10.5% | |
| Stability / Safety | Beta 0.79 vs RMBS's 3.00 | |
| Dividends | 1.4% yield; 12-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +148.9% vs SSNC's -7.3% | |
| Efficiency (ROA) | 15.5% ROA vs SLAB's -5.1%, ROIC 17.1% vs -6.9% |
RMBS vs SSNC vs IPGP vs CEVA vs SLAB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RMBS vs SSNC vs IPGP vs CEVA vs SLAB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
RMBS leads in 3 of 6 categories
SSNC leads 2 • IPGP leads 0 • CEVA leads 0 • SLAB leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
RMBS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SSNC is the larger business by revenue, generating $6.4B annually — 59.6x CEVA's $108M. RMBS is the more profitable business, keeping 31.9% of every revenue dollar as net income compared to CEVA's -10.5%. On growth, SLAB holds the edge at +25.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $721M | $6.4B | $1.0B | $108M | $785M |
| EBITDAEarnings before interest/tax | $288M | $2.0B | $55M | -$7M | -$32M |
| Net IncomeAfter-tax profit | $230M | $810M | $29M | -$11M | -$65M |
| Free Cash FlowCash after capex | $335M | $1.7B | $8M | -$6M | $66M |
| Gross MarginGross profit ÷ Revenue | +77.0% | +48.0% | +37.6% | +87.2% | +58.2% |
| Operating MarginEBIT ÷ Revenue | +35.9% | +23.1% | +0.3% | -10.1% | -9.0% |
| Net MarginNet income ÷ Revenue | +31.9% | +12.6% | +2.8% | -10.5% | -8.3% |
| FCF MarginFCF ÷ Revenue | +46.5% | +26.7% | +0.8% | -6.0% | +8.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.1% | +8.8% | +16.6% | +4.3% | +25.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -1.8% | +8.3% | -54.4% | -2.0% | +88.8% |
Valuation Metrics
SSNC leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 22.2x trailing earnings, SSNC trades at a 84% valuation discount to IPGP's 139.2x P/E. On an enterprise value basis, SSNC's 9.8x EV/EBITDA is more attractive than IPGP's 48.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $13.7B | $16.9B | $4.3B | $810M | $7.2B |
| Enterprise ValueMkt cap + debt − cash | $13.6B | $21.0B | $3.9B | $797M | $6.8B |
| Trailing P/EPrice ÷ TTM EPS | 60.00x | 22.25x | 139.22x | -91.14x | -109.92x |
| Forward P/EPrice ÷ next-FY EPS est. | 42.88x | 10.14x | 62.62x | 67.35x | 80.41x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.69x | — | — | — |
| EV / EBITDAEnterprise value multiple | 46.57x | 9.81x | 48.90x | — | — |
| Price / SalesMarket cap ÷ Revenue | 19.35x | 2.70x | 4.30x | 7.57x | 9.14x |
| Price / BookPrice ÷ Book value/share | 10.18x | 2.56x | 2.04x | 2.99x | 6.51x |
| Price / FCFMarket cap ÷ FCF | 41.10x | 10.17x | — | 1569.47x | 109.03x |
Profitability & Efficiency
RMBS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
RMBS delivers a 17.4% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-6 for SLAB. CEVA carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to SSNC's 1.10x. On the Piotroski fundamental quality scale (0–9), RMBS scores 6/9 vs SLAB's 5/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +17.4% | +11.6% | +1.4% | -4.2% | -5.9% |
| ROA (TTM)Return on assets | +15.5% | +4.1% | +1.2% | -3.7% | -5.1% |
| ROICReturn on invested capital | +17.1% | +8.9% | +0.6% | -2.3% | -6.9% |
| ROCEReturn on capital employed | +19.5% | +9.5% | +0.6% | -2.7% | -6.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.03x | 1.10x | — | 0.02x | — |
| Net DebtTotal debt minus cash | -$139M | $4.1B | -$404M | -$13M | -$364M |
| Cash & Equiv.Liquid assets | $183M | $3.6B | $404M | $18M | $364M |
| Total DebtShort + long-term debt | $44M | $7.6B | $0 | $6M | $0 |
| Interest CoverageEBIT ÷ Interest expense | 217.32x | 4.80x | — | — | -58.63x |
Total Returns (Dividends Reinvested)
RMBS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RMBS five years ago would be worth $65,393 today (with dividends reinvested), compared to $5,151 for IPGP. Over the past 12 months, RMBS leads with a +148.9% total return vs SSNC's -7.3%. The 3-year compound annual growth rate (CAGR) favors RMBS at 37.7% vs IPGP's -4.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +27.5% | -18.0% | +35.8% | +50.4% | +65.0% |
| 1-Year ReturnPast 12 months | +148.9% | -7.3% | +75.6% | +59.5% | +100.3% |
| 3-Year ReturnCumulative with dividends | +161.1% | +30.9% | -12.7% | +31.6% | +59.0% |
| 5-Year ReturnCumulative with dividends | +553.9% | +1.7% | -48.5% | -35.4% | +61.0% |
| 10-Year ReturnCumulative with dividends | +1011.5% | +164.9% | +20.2% | +27.2% | +375.0% |
| CAGR (3Y)Annualised 3-year return | +37.7% | +9.4% | -4.4% | +9.6% | +16.7% |
Risk & Volatility
Evenly matched — SSNC and SLAB each lead in 1 of 2 comparable metrics.
Risk & Volatility
SSNC is the less volatile stock with a 0.79 beta — it tends to amplify market swings less than RMBS's 3.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SLAB currently trades 99.5% from its 52-week high vs IPGP's 65.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.00x | 0.79x | 1.80x | 2.76x | 1.25x |
| 52-Week HighHighest price in past year | $161.80 | $91.07 | $155.82 | $34.87 | $218.66 |
| 52-Week LowLowest price in past year | $49.61 | $65.06 | $53.98 | $17.02 | $106.01 |
| % of 52W HighCurrent price vs 52-week peak | +78.2% | +77.0% | +65.2% | +96.7% | +99.5% |
| RSI (14)Momentum oscillator 0–100 | 58.3 | 48.3 | 39.7 | 78.9 | 66.1 |
| Avg Volume (50D)Average daily shares traded | 2.2M | 2.5M | 510K | 498K | 465K |
Analyst Outlook
SSNC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: RMBS as "Buy", SSNC as "Buy", IPGP as "Buy", CEVA as "Buy", SLAB as "Buy". Consensus price targets imply 49.2% upside for IPGP (target: $152) vs -13.0% for CEVA (target: $29). SSNC is the only dividend payer here at 1.43% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $135.67 | $94.20 | $151.67 | $29.33 | $211.60 |
| # AnalystsCovering analysts | 14 | 24 | 27 | 23 | 37 |
| Dividend YieldAnnual dividend ÷ price | — | +1.4% | — | — | — |
| Dividend StreakConsecutive years of raises | — | 12 | 1 | — | — |
| Dividend / ShareAnnual DPS | — | $1.00 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +6.1% | +1.3% | +1.0% | 0.0% |
RMBS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SSNC leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
RMBS vs SSNC vs IPGP vs CEVA vs SLAB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RMBS or SSNC or IPGP or CEVA or SLAB a better buy right now?
For growth investors, Silicon Laboratories Inc.
(SLAB) is the stronger pick with 34. 3% revenue growth year-over-year, versus 2. 7% for IPG Photonics Corporation (IPGP). SS&C Technologies Holdings, Inc. (SSNC) offers the better valuation at 22. 2x trailing P/E (10. 1x forward), making it the more compelling value choice. Analysts rate Rambus Inc. (RMBS) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RMBS or SSNC or IPGP or CEVA or SLAB?
On trailing P/E, SS&C Technologies Holdings, Inc.
(SSNC) is the cheapest at 22. 2x versus IPG Photonics Corporation at 139. 2x. On forward P/E, SS&C Technologies Holdings, Inc. is actually cheaper at 10. 1x.
03Which is the better long-term investment — RMBS or SSNC or IPGP or CEVA or SLAB?
Over the past 5 years, Rambus Inc.
(RMBS) delivered a total return of +553. 9%, compared to -48. 5% for IPG Photonics Corporation (IPGP). Over 10 years, the gap is even starker: RMBS returned +1011% versus IPGP's +20. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RMBS or SSNC or IPGP or CEVA or SLAB?
By beta (market sensitivity over 5 years), SS&C Technologies Holdings, Inc.
(SSNC) is the lower-risk stock at 0. 79β versus Rambus Inc. 's 3. 00β — meaning RMBS is approximately 279% more volatile than SSNC relative to the S&P 500. On balance sheet safety, CEVA, Inc. (CEVA) carries a lower debt/equity ratio of 2% versus 110% for SS&C Technologies Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RMBS or SSNC or IPGP or CEVA or SLAB?
By revenue growth (latest reported year), Silicon Laboratories Inc.
(SLAB) is pulling ahead at 34. 3% versus 2. 7% for IPG Photonics Corporation (IPGP). On earnings-per-share growth, the picture is similar: IPG Photonics Corporation grew EPS 117. 8% year-over-year, compared to 5. 0% for SS&C Technologies Holdings, Inc.. Over a 3-year CAGR, RMBS leads at 15. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RMBS or SSNC or IPGP or CEVA or SLAB?
Rambus Inc.
(RMBS) is the more profitable company, earning 32. 6% net margin versus -8. 3% for Silicon Laboratories Inc. — meaning it keeps 32. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RMBS leads at 36. 8% versus -9. 0% for SLAB. At the gross margin level — before operating expenses — CEVA leads at 88. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RMBS or SSNC or IPGP or CEVA or SLAB more undervalued right now?
On forward earnings alone, SS&C Technologies Holdings, Inc.
(SSNC) trades at 10. 1x forward P/E versus 80. 4x for Silicon Laboratories Inc. — 70. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IPGP: 49. 2% to $151. 67.
08Which pays a better dividend — RMBS or SSNC or IPGP or CEVA or SLAB?
In this comparison, SSNC (1.
4% yield) pays a dividend. RMBS, IPGP, CEVA, SLAB do not pay a meaningful dividend and should not be held primarily for income.
09Is RMBS or SSNC or IPGP or CEVA or SLAB better for a retirement portfolio?
For long-horizon retirement investors, SS&C Technologies Holdings, Inc.
(SSNC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 79), 1. 4% yield, +164. 9% 10Y return). CEVA, Inc. (CEVA) carries a higher beta of 2. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SSNC: +164. 9%, CEVA: +27. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RMBS and SSNC and IPGP and CEVA and SLAB?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: RMBS is a mid-cap high-growth stock; SSNC is a mid-cap quality compounder stock; IPGP is a small-cap quality compounder stock; CEVA is a small-cap quality compounder stock; SLAB is a small-cap high-growth stock. SSNC pays a dividend while RMBS, IPGP, CEVA, SLAB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.